お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989555

鎮痛薬市場調査レポート:タイプ別(非オピオイドおよびオピオイド)、投与経路別(静脈内、経口、直腸、局所、および経皮)-2025年までの世界予測-COVID-19の累積的影響

Analgesics Market Research Report by Type (Non-opioids and Opioids), by Route of Administration (Intravenous, Oral, Rectal, Topical, and Transdermal) - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
鎮痛薬市場調査レポート:タイプ別(非オピオイドおよびオピオイド)、投与経路別(静脈内、経口、直腸、局所、および経皮)-2025年までの世界予測-COVID-19の累積的影響
出版日: 2021年02月09日
発行: 360iResearch LLP
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の鎮痛薬の市場規模は、2020年の171億2367万米ドルから、2025年末までに248億8592万米ドルに成長すると予想されています。

COVID-19の累積的影響

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮したCOVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

レポートは次のような質問に答えます。

  • 1.世界の鎮痛薬市場の市場規模と予測はどのくらいですか?
  • 2.予測期間中に世界の鎮痛薬市場を形成するCOVID-19の阻害要因と影響は何ですか?
  • 3.世界の鎮痛薬市場の予測期間中に投資する製品/セグメント/アプリケーション/領域はどれですか?
  • 4.世界の鎮痛薬市場における機会の競争戦略ウィンドウは何ですか?
  • 5.世界の鎮痛薬市場動向技術動向と規制の枠組みは何ですか?
  • 6.世界の鎮痛薬市場に参入するのに適していると考えられるモードと戦略的動きは何ですか?

当レポートでは、鎮痛薬市場を調査し、市場概要、市場の成長要因および阻害要因の分析、タイプ別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 投与経路の見通し
  • タイプ別の見通し
  • 地域別の見通し
  • 競合他社の見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 タイプ別の世界の鎮痛薬市場

  • イントロダクション
  • 非オピオイド
  • オピオイド

第7章 投与経路別の世界の鎮痛薬市場

  • イントロダクション
  • 静脈内
  • オーラル
  • 直腸
  • 局所
  • 経皮吸収

第8章 南北アメリカの鎮痛薬市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋鎮痛薬市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第10章 欧州、中東・アフリカの鎮痛薬市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第12章 企業のユーザビリティプロファイル

  • Abbott Laboratories
  • AbbVie Inc.
  • Aspen Pharmacare Holdings Limited
  • Astrazeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Braun Melsungen AG
  • Claris Life sciences
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd
  • Fresenius SE & Co. KGaA
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Hospira, Inc
  • Maruishi Pharmaceutical Co., Ltd.
  • Mylan NV
  • Pacira Pharmaceuticals, Inc.
  • Paion UK Ltd
  • Pfizer Inc.
  • Piramal Enterprises LTD
  • Septodont
  • Teva Pharmaceutical Industries Limited
  • Troikaa Pharmaceuticals Ltd

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

List of Figures

  • FIGURE 1. GLOBAL ANALGESICS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ANALGESICS MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ANALGESICS MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ANALGESICS MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 8. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 9. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 11. GLOBAL ANALGESICS MARKET: MARKET DYNAMICS
  • FIGURE 12. GLOBAL ANALGESICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 13. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
  • FIGURE 14. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2025
  • FIGURE 16. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
  • FIGURE 19. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
  • FIGURE 21. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 27. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 29. ARGENTINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 30. BRAZIL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 31. CANADA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 32. MEXICO ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 33. UNITED STATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 35. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 37. AUSTRALIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 38. CHINA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. INDIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 40. INDONESIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. JAPAN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. MALAYSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. PHILIPPINES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. SOUTH KOREA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. THAILAND ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 47. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 49. FRANCE ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. GERMANY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. ITALY ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. NETHERLANDS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. QATAR ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. RUSSIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. SAUDI ARABIA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. SOUTH AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. SPAIN ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. UNITED KINGDOM ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 60. GLOBAL ANALGESICS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 61. GLOBAL ANALGESICS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 62. GLOBAL ANALGESICS MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANALGESICS MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL ANALGESICS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. BRAZIL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CANADA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. MEXICO ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. AUSTRALIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. AUSTRALIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CHINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. CHINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. INDIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. INDIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. INDONESIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. INDONESIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. JAPAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. JAPAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. MALAYSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. MALAYSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. PHILIPPINES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. PHILIPPINES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. SOUTH KOREA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. SOUTH KOREA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. THAILAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. THAILAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. FRANCE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. FRANCE ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. GERMANY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. GERMANY ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. ITALY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. ITALY ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. NETHERLANDS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. NETHERLANDS ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. QATAR ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. QATAR ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. RUSSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. RUSSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. SAUDI ARABIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. SAUDI ARABIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. SOUTH AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SOUTH AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. SPAIN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. SPAIN ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. UNITED KINGDOM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. UNITED KINGDOM ANALGESICS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. GLOBAL ANALGESICS MARKET: SCORES
  • TABLE 73. GLOBAL ANALGESICS MARKET: BUSINESS STRATEGY
  • TABLE 74. GLOBAL ANALGESICS MARKET: PRODUCT SATISFACTION
  • TABLE 75. GLOBAL ANALGESICS MARKET: RANKING
  • TABLE 76. GLOBAL ANALGESICS MARKET: MERGER & ACQUISITION
  • TABLE 77. GLOBAL ANALGESICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 78. GLOBAL ANALGESICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 79. GLOBAL ANALGESICS MARKET: INVESTMENT & FUNDING
  • TABLE 80. GLOBAL ANALGESICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 81. GLOBAL ANALGESICS MARKET: LICENSE & PRICING
目次
Product Code: MRR-DA0518C

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

  • 1. The Global Analgesics Market is expected to grow from USD 17,123.67 Million in 2020 to USD 24,885.92 Million by the end of 2025.
  • 2. The Global Analgesics Market is expected to grow from EUR 15,014.35 Million in 2020 to EUR 21,820.44 Million by the end of 2025.
  • 3. The Global Analgesics Market is expected to grow from GBP 13,347.79 Million in 2020 to GBP 19,398.42 Million by the end of 2025.
  • 4. The Global Analgesics Market is expected to grow from JPY 1,827,529.50 Million in 2020 to JPY 2,655,958.27 Million by the end of 2025.
  • 5. The Global Analgesics Market is expected to grow from AUD 24,865.84 Million in 2020 to AUD 36,137.66 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Analgesics to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the Analgesics Market studied across Non-opioids and Opioids.
  • Based on Route of Administration, the Analgesics Market studied across Intravenous, Oral, Rectal, Topical, and Transdermal.
  • Based on Geography, the Analgesics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Analgesics Market including Abbott Laboratories, AbbVie Inc., Aspen Pharmacare Holdings Limited, Astrazeneca PLC, B. Braun Melsungen AG, Baxter International Inc., Boehringer Ingelheim International GmbH, Braun Melsungen AG, Claris Life sciences, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals PLC, Hospira, Inc, Maruishi Pharmaceutical Co., Ltd., Mylan NV, Pacira Pharmaceuticals, Inc., Paion UK Ltd, Pfizer Inc., Piramal Enterprises LTD, Septodont, Teva Pharmaceutical Industries Limited, and Troikaa Pharmaceuticals Ltd.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Analgesics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Analgesics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Analgesics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Analgesics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Analgesics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Analgesics Market?
  • 6. What are the modes and strategic moves considered suitable for entering the Global Analgesics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Route of Administration Outlook
  • 3.4. Type Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
      • 5.1.1.2. Frequent pain and aches encountered by the aging population
      • 5.1.1.3. Cost-efficiency of OTC analgesics drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D by the public & private sectors
      • 5.1.3.2. Surge in popularity of personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Analgesics Market, By Type

  • 6.1. Introduction
  • 6.2. Non-opioids
  • 6.3. Opioids

7. Global Analgesics Market, By Route of Administration

  • 7.1. Introduction
  • 7.2. Intravenous
  • 7.3. Oral
  • 7.4. Rectal
  • 7.5. Topical
  • 7.6. Transdermal

8. Americas Analgesics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Analgesics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. South Korea
  • 9.10. Thailand

10. Europe, Middle East & Africa Analgesics Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis
  • 11.4. Competitor SWOT Analysis
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. AbbVie Inc.
  • 12.3. Aspen Pharmacare Holdings Limited
  • 12.4. Astrazeneca PLC
  • 12.5. B. Braun Melsungen AG
  • 12.6. Baxter International Inc.
  • 12.7. Boehringer Ingelheim International GmbH
  • 12.8. Braun Melsungen AG
  • 12.9. Claris Life sciences
  • 12.10. Eisai Co. Ltd.
  • 12.11. F. Hoffmann-La Roche Ltd
  • 12.12. Fresenius SE & Co. KGaA
  • 12.13. Glenmark Pharmaceuticals Limited
  • 12.14. Hikma Pharmaceuticals PLC
  • 12.15. Hospira, Inc
  • 12.16. Maruishi Pharmaceutical Co., Ltd.
  • 12.17. Mylan NV
  • 12.18. Pacira Pharmaceuticals, Inc.
  • 12.19. Paion UK Ltd
  • 12.20. Pfizer Inc.
  • 12.21. Piramal Enterprises LTD
  • 12.22. Septodont
  • 12.23. Teva Pharmaceutical Industries Limited
  • 12.24. Troikaa Pharmaceuticals Ltd

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.